Wealthfront Advisers’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Wealthfront Advisers's ALAB Position: Q2 2026 in Review
Wealthfront Advisers increased its Astera Labs (ALAB) stake by 4.9% in Q2 2026, buying an estimated $34.8K and bringing the position to 2,794 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #683.
Wealthfront Advisers first reported a position in ALAB in Q4 2025 and has held it in 3 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Wealthfront Advisers held 2,794 shares of Astera Labs worth $1.35M as of Q2 2026.
- Wealthfront Advisers bought 131 Astera Labs shares in Q2 2026, an estimated $34.8K.
- Astera Labs made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #683 holding.
- Wealthfront Advisers first reported a position in Astera Labs in Q4 2025 and has held it in 3 quarters since.
- 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.